Exclusive: Of more than 1,000 medicinal cannabis products available, only two have been evaluated by the drugs regulator

Doctors are commonly prescribing high-dose medicinal cannabis containing up to four times the concentration of THC tested in clinical trials, a review has found.

Researchers from Monash University evaluated the available evidence for the efficacy and safety of higher THC potency medicinal cannabis products, in line with those being prescribed in Australia. THC, or delta-9-tetrahydrocannabinol, is the main psychoactive ingredient of cannabis.

Continue reading…

Published by Archie Watson on 28 July 2026. GEMHerald summarises reporting from other outlets and links to the original. Read our editorial policy and how we handle corrections.